193 related articles for article (PubMed ID: 2753751)
1. Epidemiology of Hodgkin's disease.
Rothman H; Freed N
J Am Osteopath Assoc; 1989 Jun; 89(6):783-6. PubMed ID: 2753751
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
3. Childhood social environment and Hodgkin's lymphoma: new findings from a population-based case-control study.
Chang ET; Zheng T; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1361-70. PubMed ID: 15298959
[TBL] [Abstract][Full Text] [Related]
4. The increase of Hodgkin's disease incidence among young adults. Experience in Connecticut, 1935-1992.
Chen YT; Zheng T; Chou MC; Boyle P; Holford TR
Cancer; 1997 Jun; 79(11):2209-18. PubMed ID: 9179069
[TBL] [Abstract][Full Text] [Related]
5. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
Donaldson SS; Hancock SL; Hoppe RT
Cancer J Sci Am; 1999; 5(6):325-33. PubMed ID: 10606471
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's Disease, tonsillectomy and family size.
Gutensohn N; Li FP; Johnson RE; Cole P
N Engl J Med; 1975 Jan; 292(1):22-5. PubMed ID: 1109186
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease in siblings: a case report.
Durosinmi MA; Nwosu SO; Ogunniyi JO; Dada O; Okunlola MA
Afr J Med Med Sci; 1989 Sep; 18(3):219-22. PubMed ID: 2551163
[TBL] [Abstract][Full Text] [Related]
8. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
9. [Clusters of Hodgkin's disease. Case report of two brothers].
Petzoldt R; Hartwich G
Med Klin; 1975 Jan; 70(2):62-4. PubMed ID: 1113700
[TBL] [Abstract][Full Text] [Related]
10. EBV-associated recurrent Hodgkin's disease after renal transplantation.
Flanagan KH; Brennan DC
Transpl Int; 2006 Apr; 19(4):338-41. PubMed ID: 16573551
[TBL] [Abstract][Full Text] [Related]
11. Childbearing and the risk of Hodgkin's disease.
Lambe M; Hsieh CC; Tsaih SW; Adami J; Glimelius B; Adami HO
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):831-4. PubMed ID: 9752994
[TBL] [Abstract][Full Text] [Related]
12. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
13. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
14. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
15. Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.
Dutton A; Burns AT; Young LS; Murray PG
Expert Rev Anticancer Ther; 2006 Jun; 6(6):911-9. PubMed ID: 16761935
[TBL] [Abstract][Full Text] [Related]
16. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's and non-Hodgkin's lymphomas.
Hartge P; Devesa SS; Fraumeni JF
Cancer Surv; 1994; 19-20():423-53. PubMed ID: 7534635
[TBL] [Abstract][Full Text] [Related]
18. Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993.
Broccia G; Cocco P; Casula P;
Haematologica; 2001 Jan; 86(1):58-63. PubMed ID: 11146572
[TBL] [Abstract][Full Text] [Related]
19. [Epstein-Barr virus and Hodgkin's lymphoma].
Hjalgrim H; Munksgaard L; Melbye M
Ugeskr Laeger; 2002 Dec; 164(50):5924-7. PubMed ID: 12553111
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Hodgkin's disease.
Meyer SA; Thar T
Am Fam Physician; 1981 Nov; 24(5):217-21. PubMed ID: 7293915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
